You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

gm-csf

Showing 1 - 25 of 81
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Objective Response Rate Trial in Wuhan (GM-CSF)

Recruiting
  • Objective Response Rate
  • GM-CSF
  • Wuhan, Hubei, China
    Renmin Hospital of Wuhan University
Feb 25, 2023

Neuroblastoma Trial in New York (dietary supplement, drug, biological)

Recruiting
  • Neuroblastoma
  • β-glucan
  • +2 more
  • New York, New York
    Memorial Sloan Kettering Cancer Center
Dec 5, 2022

Neuroblastoma Trial in New York (Hu3F8, GM-CSF, Isotretinoin)

Active, not recruiting
  • Neuroblastoma
  • Hu3F8
  • +2 more
  • New York, New York
    Memorial Sloan Kettering Cancer Center
Jul 1, 2022

NSCLC, Carcinoma Breast Trial in Suzhou (Vinorelbine, Radiotherapy, PD-1/PD-L1 inhibitor)

Not yet recruiting
  • Carcinoma, Non-Small-Cell Lung
  • Carcinoma Breast
  • Suzhou, China
    Second Affiliated Hospital of Soochow University
Oct 29, 2022

Recurrent Osteosarcoma Trial in Los Angeles, New York, Houston (humanized anti-GD2 antibody, GM-CSF)

Recruiting
  • Recurrent Osteosarcoma
  • humanized anti-GD2 antibody
  • GM-CSF
  • Los Angeles, California
  • +2 more
Dec 22, 2022

Colorectal Tumors Trial in Xiamen (hypofractionation Radiotherapy, sintilimab, GM-CSF)

Recruiting
  • Colorectal Neoplasms
  • hypofractionation Radiotherapy
  • +3 more
  • Xiamen, Fujian, China
    The First Affiliated Hospital of Xiamen University
Mar 28, 2022

Glioma, Malignant Trial in Bangkok (ERC1671, GM-CSF, Cyclophosphamide)

Not yet recruiting
  • Glioma, Malignant
  • Bangkok, Vadhana, Thailand
    Bumrungrad International Hospital
May 9, 2022

Neuroblastoma Trial in Guangzhou (Naxitamab monotherapy, GM-CSF, Irinotecan)

Recruiting
  • Neuroblastoma
  • Naxitamab monotherapy
  • +6 more
  • Guangzhou, Guangdong, China
    Sun Yat-sen University Cancer Center
Aug 31, 2023

Glioblastoma Trial in Durham (Human CMV pp65-LAMP mRNA-pulsed autologous DCs containing GM CSF, Temozolomide, Tetanus-Diphtheria

Suspended
  • Glioblastoma
  • Human CMV pp65-LAMP mRNA-pulsed autologous DCs containing GM CSF
  • +4 more
  • Durham, North Carolina
    Duke University Medical Center
Aug 16, 2022

Metastatic Melanoma Trial in Louisville (Ipilimumab, GM-CSF)

Completed
Has Results
  • Metastatic Melanoma
  • Louisville, Kentucky
    James Graham Brown Cancer Center
Oct 22, 2021

Advanced Refractory Solid Tumors Trial in China (Hypofractionated radiotherapy, PD-1 inhibitor, GM-CSF)

Recruiting
  • Advanced Refractory Solid Tumors
  • Hypofractionated radiotherapy
  • +3 more
  • Beijing, China
  • +15 more
Aug 8, 2022

Peripheral Artery Disease (PAD) Trial in Atlanta (GM-CSF, Placebo)

Recruiting
  • Peripheral Artery Disease (PAD)
  • GM-CSF
  • Placebo
  • Atlanta, Georgia
    Emory University Hospital
Oct 8, 2021

Pediatric Sepsis-induced MODS Trial in United States (GM-CSF)

Active, not recruiting
  • Pediatric Sepsis-induced MODS
  • GM-CSF
  • Los Angeles, California
  • +7 more
Feb 24, 2022

Critical Injury (Trauma) in Children Trial in United States (GM-CSF)

Completed
  • Critical Injury (Trauma) in Children
  • GM-CSF
  • Aurora, Colorado
  • +7 more
Feb 24, 2022

Advanced Solid Tumor, Refractory Tumor Trial in Suzhou (Thymalfasin, Radiotherapy, PD-1/PD-L1 inhibitor)

Recruiting
  • Advanced Solid Tumor
  • Refractory Tumor
  • Suzhou, China
    The Second Affiliated Hospital of SchoowUniversity
Mar 29, 2023

Ovarian Cancer, Primary Peritoneal Cancer, Fallopian Tube Cancer Trial in Boston (GM-CSF, Dendritic Cell/Tumor Fusion Vaccine,

Active, not recruiting
  • Ovarian Cancer
  • +2 more
  • GM-CSF
  • +2 more
  • Boston, Massachusetts
  • +3 more
Jan 25, 2022

Neuroblastoma Trial in Cologne (antibody ch14.18, GM-CSF, IL-2 i.v.)

Terminated
  • Neuroblastoma
  • antibody ch14.18
  • +4 more
  • Cologne, Germany
    University of Cologne
Nov 3, 2022

Mantle Cell Lymphoma, Lymphoma, Mantle Cell Trial run by the NCI (EPOCH-R, GM-CSF, Idiotype vaccine)

Completed
Has Results
  • Mantle Cell Lymphoma
  • Lymphoma, Mantle Cell
  • Bethesda, Maryland
    National Institutes of Health Clinical Center, 9000 Rockville Pi
Jan 4, 2023

Malignant Melanoma Trial in United States (UV1, GM-CSF)

Active, not recruiting
  • Malignant Melanoma
  • Santa Monica, California
  • +3 more
Nov 16, 2022

Solid Tumors, Lung Adenocarcinoma, Osteosarcoma Trial in Tianjin (IBI188, GM-CSF, Cisplatin/Carboplatin)

Terminated
  • Solid Tumors
  • +2 more
  • Tianjin, China
    Tianjin Medical University Cancer Institute and Hospital
Oct 3, 2022

Pediatric Sepsis-induced Multiple Organ Dysfunction Syndrome Trial in United States (GM-CSF, Placebo)

Not yet recruiting
  • Pediatric Sepsis-induced Multiple Organ Dysfunction Syndrome
  • GM-CSF
  • Placebo
  • Little Rock, Arkansas
  • +25 more
May 8, 2022

Breast Cancer Trial in United States (NeuVax vaccine, Trastuzumab, GM-CSF)

Completed
  • Breast Cancer
  • NeuVax vaccine
  • +2 more
  • Santa Monica, California
  • +23 more
Sep 15, 2022

Neuroblastoma (NB) Trial in New York (Irinotecan, temozolomide, Hu3F8)

Active, not recruiting
  • Neuroblastoma (NB)
  • New York, New York
    Memorial Sloan Kettering Cancer Center
Oct 19, 2021

Prostate Cancer Trial in Madison (pTVG-HP, Nivolumab, GM-CSF)

Active, not recruiting
  • Prostate Cancer
  • pTVG-HP
  • +2 more
  • Madison, Wisconsin
    University of Wisconsin Carbone Cancer Center
Feb 7, 2022

Neuroblastoma Trial in Worldwide (Naxitamab, GM-CSF, Isotretinoin)

Recruiting
  • Neuroblastoma
  • Kowloon, Hong Kong
  • +8 more
Jan 31, 2022